Tai Ching Ho

Tai Ching Ho

Plus aucun poste en cours
64 ans
Health Technology
Consumer Services
Commercial Services

Profil

Tai Ching Ho is the founder of two companies.
He founded BeiGene Ltd. in 2010 and served as President from 2010 to 2012.
He also founded Metastagen, Inc. in 2013 and served as Chief Executive Officer from 2013 to 2014.
Dr. Ho held several former jobs, including Vice President-Oncology Development at Johnson & Johnson from 2008 to 2010, Chief Medical Officer & Executive Vice President at Epizyme, Inc. from 2015 to 2017, and Senior Vice President-Oncology Center at GlaxoSmithKline LLC.
He was also Chief Medical Officer at Boston Pharmaceuticals, Inc. from 2018 to 2020 and Independent Director at Aravive, Inc. from 2021 to 2024.
Dr. Ho received his undergraduate degree from The Johns Hopkins University and his doctorate from Yale School of Medicine.

Anciens postes connus de Tai Ching Ho

SociétésPosteFin
ARAVIVE, INC. Directeur/Membre du Conseil 17/01/2024
Directeur Technique/Scientifique/R&D 01/01/2020
EPIZYME, INC. Directeur Technique/Scientifique/R&D 31/12/2017
Directeur Général 01/09/2014
BEIGENE LTD Fondateur 01/12/2012
Voir l'expérience en détail de Tai Ching Ho

Formation de Tai Ching Ho

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

46

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Tai Ching Ho
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇